Fox Run Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,667	Closed	-$1.39M	–	1293
2024 Q4	$1.39M	Buy	+16,667	New	+$1.37M	0.25%	72
2024 Q3	–	Sell	-18,575	Closed	-$1.27M	–	1169
2024 Q2	$1.27M	Buy	+18,575	New	+$1.29M	0.24%	111
2024 Q1	–	Sell	-3,289	Closed	-$236K	–	1119
2023 Q4	$236K	Buy	+3,289	New	+$189K	0.06%	584
2022 Q4	–	Sell	-8,357	Closed	-$389K	–	936
2022 Q3	$389K	Sell	8,357 -359	-4%	-$18.8K	0.15%	261
2022 Q2	$498K	Buy	+8,716	New	+$494K	0.25%	120
2020 Q4	–	Sell	-10,882	Closed	-$279K	–	303
2020 Q3	$279K	Buy	+10,882	New	+$248K	0.7%	50
2018 Q4	–	Sell	-10,109	Closed	-$219K	–	780
2018 Q3	$219K	Sell	10,109 -20,053	-66%	-$419K	0.1%	455
2018 Q2	$533K	Buy	+30,162	New	+$612K	0.17%	217
2018 Q1	–	Sell	-26,625	Closed	-$386K	–	967
2017 Q4	$386K	Buy	26,625 +1,925	+8%	+$29.7K	0.11%	374
2017 Q3	$390K	Buy	+24,700	New	+$362K	0.11%	387
2017 Q1	–	Sell	-15,300	Closed	-$231K	–	780
2016 Q4	$231K	Buy	+15,300	New	+$216K	0.12%	390
2016 Q3	–	Sell	-8,200	Closed	-$318K	–	728
2016 Q2	$318K	Buy	+8,200	New	+$295K	0.15%	268